We are pleased to announce that Acellmed’s project, submitted together with the Silesian Park of Medical Technology Kardio-Med Silesia, was ranked 1^st on the list of the best projects in the competition organized by the Silesian Centre for Entrepreneurship (European Regional Development Fund under the Regional Operational Programme of the Silesian Voivodeship for 2014-2020 from Priority Axis I. Modern Economy Measure 1.2 Research, Development and Innovation in Enterprises).

Our project entitled: “Personalized liposome therapy of acute myeloid leukemia (OBS/AML) based on small inhibitory RNAs” received the highest number of points from the committee and funding for the designed research.

Congratulations to the whole team!

For more information, please check out here.